{"ticker": {"uuid": "99f875a4-3524-4442-b68c-34160072ecaf", "symbol": "GELS", "name": "Gelteq Limited Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Gelteq(GELS) Stock Options Chain | Quotes & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwJBVV95cUxPX2hyakR1bEQ0aUd0dDJvNzVWRHRCa2hQd2FvMU9UWjBDYnJ1bUZwcnRNc2doNk1QajVPYkJ1blVwX1dZMlBQdUhPaThwT3dHRDRaVTdBQ3E1WWhPbHJ5U19Dckh5cW9ZaW5DNjVEQVRSbDlPQUdlVTlya3JHeWwzMlkzQnBocW1oNXE3eGZ1YUE2R1Zub184VWQ2bDhjUGVnbEJNNzRnUkxFQUVuTmVrUnJjMjliY0lTYWc1ZVhDTmtyTFF2SEw5Y3RMS0Y0MjM2R1hYQVdfLWx1dWNrMmhJVXU0b1JoMXBLUTlzbXlmTDQ5RzkydFp1WkhOSFFmSno2Yy1GMDN6WDkzY0xOUUhlaW12eUYxYnRQaHhXV2h6bklpNDVWeDN3TlRRbw?oc=5", "source_name": "Moomoo", "published_at": "2026-07-14T01:56:25+00:00", "published_display": "14 Jul 2026 01:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq (GELS) wins shareholder approval and closes $2.5M second tranche note", "summary": "Gelteq Limited (GELS) announced that its shareholders approved a debt financing proposal, allowing the company to close the second tranche of a convertible debt facility. This approval led to Gelteq receiving $2.5 million in proceeds from an institutional investor, net of a $375,", "url": "https://www.stocktitan.net/sec-filings/GELS/6-k-gelteq-ltd-current-report-foreign-issuer-a2a80269a743.html", "source_name": "Stock Titan", "published_at": "2026-07-03T03:10:07", "published_display": "03 Jul 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GELS - Gelteq Ltd Short Interest", "summary": "This article provides a detailed overview of Gelteq Ltd's (GELS) short interest and key financial metrics as of July 1, 2026. It includes stock performance, valuation ratios, income statement data, balance sheet figures, and insider/institutional ownership percentages. The data i", "url": "https://finviz.com/stock?t=GELS&ta=1&p=d&ty=si&b=1", "source_name": "Finviz", "published_at": "2026-07-01T14:09:15", "published_display": "01 Jul 2026 14:09", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GELS - Gelteq Ltd Latest SEC Filings", "summary": "This article provides the latest SEC filing information for Gelteq Ltd (GELS), including its last trading close of $0.6600 on July 1st, alongside a comprehensive overview of the company's financial data, performance metrics, and key ratios. It details market capitalization, incom", "url": "https://finviz.com/stock?t=GELS&ty=lf&page=1", "source_name": "Finviz", "published_at": "2026-07-01T07:09:15", "published_display": "01 Jul 2026 07:09", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq (GELS) faces $5.3M working capital deficit and rising debt", "summary": "Gelteq (GELS), an Australian biotech, reported a net loss of AUD$3.74 million for the six months ended December 31, 2025, and a sharp decline in cash to AUD$9,349. The company faces severe liquidity pressure with a working capital deficit of AUD$5.34 million and rising total borr", "url": "https://www.stocktitan.net/sec-filings/GELS/6-k-gelteq-ltd-current-report-foreign-issuer-06b43cfff8a6.html", "source_name": "Stock Titan", "published_at": "2026-06-30T21:39:46", "published_display": "30 Jun 2026 21:39", "sentiment": "negative", "sentiment_pct": 13, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Ltd (GELS) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Gelteq Ltd (GELS), including its current stock performance, market capitalization, and various analytical dimensions like financial health, valuation, price momentum, and risk assessment. It highlights that critical data for EPS, Rev", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-gels/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T09:09:40", "published_display": "18 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Ltd (GELS) Institutional Confidence", "summary": "This article provides details on the institutional confidence score for Gelteq Ltd (GELS), including its current stock price, market cap, and a list of major institutional shareholders. It highlights the shares held by key individuals and firms, as well as recent changes in their", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-gels/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T06:09:40", "published_display": "18 Jun 2026 06:09", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Ltd (GELS) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a brief valuation analysis for Gelteq Ltd (GELS), highlighting key financial metrics such as P/E, P/B, P/S, and P/CF ratios. It notes that relevant data for these metrics have not yet been disclosed by the company. The article also includes current stock per", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-gels/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T03:09:22", "published_display": "18 Jun 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Ltd (GELS) Financial Health: Profitability & Balance Sheet Analysis", "summary": "The article provides an analysis of Gelteq Ltd's (GELS) financial health, focusing on profitability and balance sheet aspects. It notes that relevant financial data for several key metrics, including cash and cash equivalents, total assets, operating profit, and free cash flow, h", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-gels/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T21:09:22", "published_display": "17 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs", "summary": "Gelteq has announced a significant corporate update, detailing the launch of both veterinary and human clinical trials for its patented technology. The company also reported an expansion of its pharmaceutical pipeline across multiple programs, indicating a broader application of ", "url": "https://news.futunn.com/en/post/74731578/gelteq-provides-corporate-update-launching-veterinary-and-human-clinical-trials", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-06-17T20:09:16", "published_display": "17 Jun 2026 20:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Ltd (GELS) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides historical dividend and stock split information for Gelteq Ltd (GELS). It notes that Gelteq Ltd has distributed $0.00 in dividends over the past five years and currently has no recorded stock split data. The company's stock is trading at $1.040 with an 8.77%", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-gels/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T20:09:16", "published_display": "17 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq lines up first human trial, vet study and $3.5M financing", "summary": "Gelteq (NASDAQ: GELS) announced significant clinical, commercial, and financing progress, including a commenced veterinary antiparasitic trial, a first human clinical trial expected next quarter, and a preclinical diabetes study. The company secured up to $3.5 million in strategi", "url": "https://www.stocktitan.net/news/GELS/gelteq-provides-corporate-update-launching-veterinary-and-human-bpx04dh0crj7.html", "source_name": "Stock Titan", "published_at": "2026-06-17T12:40:31", "published_display": "17 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GELS - Gelteq Ltd Earnings", "summary": "This article provides comprehensive financial data for Gelteq Ltd (GELS), including its market capitalization, income, sales, and various performance metrics. It details key financial ratios, EPS figures, insider ownership, institutional ownership, and stock performance over diff", "url": "https://finviz.com/stock?t=GELS&ta=1&p=d&ty=ea&b=1", "source_name": "Finviz", "published_at": "2026-06-17T03:39:43", "published_display": "17 Jun 2026 03:39", "sentiment": "negative", "sentiment_pct": 13, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$Gelteq (GELS.US)$ thank you", "summary": "This article is a brief post from a user named \"Rakeem tha Dream\" on the Moomoo Community platform, expressing gratitude for $Gelteq (GELS.US)$. The content highlights the social interaction aspect of the platform where users can share thoughts and engage in discussions about sto", "url": "https://www.moomoo.com/community/feed/gelteq-gels-us-thank-you-116753455251461", "source_name": "Moomoo", "published_at": "2026-06-16T08:10:23", "published_display": "16 Jun 2026 08:10", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GELS Stock Rockets On Momentum As Traders Pile In", "summary": "Gelteq Limited (GELS) stock has surged by 47.47% due to strong investor optimism regarding its commercialization progress, making it a focus for momentum traders. Despite its small revenue, high price-to-sales ratio, and negative profitability, the stock has shown explosive chart", "url": "https://www.timothysykes.com/news/gelteq-limited-gels-news-2026_06_15/", "source_name": "Timothy Sykes", "published_at": "2026-06-15T13:41:39", "published_display": "15 Jun 2026 13:41", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GELS Stock Rockets On Massive Volume As Traders Pile In", "summary": "Gelteq Limited (GELS) stock surged 48.99% on massive volume, driven by speculative trading and momentum rather than strong fundamentals. The company, with minimal revenue and negative returns, is being treated by traders as a high-volatility, high-reward opportunity, with its sto", "url": "https://stockstotrade.com/news/gelteq-limited-gels-news-2026_06_15/", "source_name": "StocksToTrade", "published_at": "2026-06-15T13:41:39", "published_display": "15 Jun 2026 13:41", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$Gelteq (GELS.US)$ early catch\u2026LG\u2026\ud83c\udfce\ud83d\udc4d\ud83c\udfff\ud83d\udd25\ud83d\udd25\ud83d\udd25\ud83d\udd25\ud83d\udd25\ud83c\udfc1", "summary": "The article is a brief post from a user named Team Crawford on the moomoo platform, expressing enthusiasm for Gelteq (GELS.US). The post includes emojis suggesting excitement and a \"good game\" or \"let's go\" sentiment. It appears to be a social media-style update rather than an an", "url": "https://www.moomoo.com/community/feed/gelteq-gels-us-early-catch-lg-116732418654213", "source_name": "Moomoo", "published_at": "2026-06-15T08:40:43", "published_display": "15 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq\u00ae Technology for Animal Health Applications", "summary": "Gelteq announced the successful completion of veterinary palatability trials with Kemin Industries, validating their Gelteq\u00ae technology for animal health applications. The trials showed strong canine acceptance of products, even those with bitter compounds, confirming the technol", "url": "https://www.manilatimes.net/2026/06/13/tmt-newswire/globenewswire/gelteq-successfully-completes-veterinary-palatability-trials-with-kemin-further-validating-gelteq-technology-for-animal-health-applications/2364638", "source_name": "The Manila Times", "published_at": "2026-06-12T18:10:16", "published_display": "12 Jun 2026 18:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq's Tasty Tech May End the Pet-Pilling War and Reshape Animal Health", "summary": "Gelteq, an Australian biotech firm, has successfully completed palatability trials for its gel-based drug delivery platform, Gelteq\u00ae, in collaboration with Kemin Industries. This technology aims to solve the widespread problem of pet medication non-compliance by effectively maski", "url": "https://briefglance.com/articles/gelteqs-tasty-tech-may-end-the-pet-pilling-war-and-reshape-animal-health", "source_name": "BriefGlance", "published_at": "2026-06-12T17:41:39", "published_display": "12 Jun 2026 17:41", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dogs accept gels that hide bitter medicine, Gelteq trials show", "summary": "Gelteq (ASX:GELS) has successfully completed veterinary palatability trials with Kemin Industries, validating its gel-based delivery platform for animal health. The trials demonstrated strong canine acceptance and effective masking of bitter flavors, confirming the technology's p", "url": "https://www.stocktitan.net/news/GELS/gelteq-successfully-completes-veterinary-palatability-trials-with-dllbm93mgtvp.html", "source_name": "Stock Titan", "published_at": "2026-06-12T16:29:31", "published_display": "12 Jun 2026 16:29", "sentiment": "positive", "sentiment_pct": 90, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Going On With Gelteq Stock Friday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPc1VBZTFOUWtPZWZ4Z1hIdjlITTZBd21fRFcybUZPdVhLT2dRUFZhQUE1N2QyRVpYRWtKZ3JwR3hzVGQ5NXhHV1JSQVZvZWRpQjh0bnhpUmZiNG82RDgzQWViakZOTWR6aWNWVkhuU1RBU0R1NGh4bG5CR3E1elVrZFh6MXBBa1YtaTI3MDB0SVF4MHVWbGc?oc=5", "source_name": "Sahm", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Jumps After GELS Hits Several Nasdaq Volatility Pauses", "summary": "Shares of Gelteq Limited (NASDAQ: GELS) surged by about 56% to $0.805 on June 11, 2026, experiencing multiple Nasdaq volatility pauses as its stock price fluctuated significantly between $0.5145 and $2.01 with exceptionally high trading volume. The surge comes as the Melbourne-ba", "url": "https://ts2.tech/en/gelteq-jumps-after-gels-hits-several-nasdaq-volatility-pauses/", "source_name": "TechStock\u00b2", "published_at": "2026-06-11T18:39:08", "published_display": "11 Jun 2026 18:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq (Nasdaq:GELS) - Stock Analysis", "summary": "This Simply Wall St analysis of Gelteq (Nasdaq:GELS) highlights its current stock performance, fundamental statistics, and recent company announcements. The report details the company's valuation, growth prospects, financial health, and risks, including its highly volatile share ", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gels/gelteq", "source_name": "Simply Wall Street", "published_at": "2026-06-11T17:09:27", "published_display": "11 Jun 2026 17:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$Gelteq (GELS.US)$ \ud83d\udc4d sold all already. thank you![Drool][Cool Guy][Rich][Peace][Blessing]", "summary": "A Moomoo user, ABC88, announced that they have sold all their shares in Gelteq (GELS.US), expressing gratitude. The post, made in the Moomoo Community, includes various emojis suggesting satisfaction and profit.", "url": "https://www.moomoo.com/community/feed/gelteq-gels-us-sold-all-already-thank-you-116733309288454", "source_name": "Moomoo", "published_at": "2026-06-11T07:39:07", "published_display": "11 Jun 2026 07:39", "sentiment": "positive", "sentiment_pct": 68, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq establishes Centre of Excellence in China to accelerate product development", "summary": "Australia-based Gelteq has announced the establishment of a new Centre of Excellence in Guangdong Province, China. This strategic regional hub will strengthen Gelteq's globally integrated development platform by leveraging local infrastructure, technical expertise, and innovation", "url": "https://www.biospectrumasia.com/news/26/27748/gelteq-establishes-centre-of-excellence-in-china-to-accelerate-product-development-.html", "source_name": "BioSpectrum Asia", "published_at": "2026-06-05T15:40:18", "published_display": "05 Jun 2026 15:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion", "summary": "Gelteq (GELS) has announced the establishment of a new Center of Excellence in Guangdong Province, China, aiming to accelerate product development and commercial expansion. This strategic hub will provide access to China's growing biotech and pharma ecosystem, enhancing formulati", "url": "https://www.stocktitan.net/news/GELS/gelteq-establishes-center-of-excellence-in-china-to-accelerate-vhfqa5qhaawp.html", "source_name": "Stock Titan", "published_at": "2026-06-04T12:39:08", "published_display": "04 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq sets up Guangdong hub as China biotech deals near $60B", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOcF9ONmRSSEdLUHhmOUdPdi1GTTBlNjI0SmJlaV9JZGdzRUlTbnBiMkN5NFZtVlVkLUE0aUsxWWtLUy1yc1VObmlfdDFEbFpBc0xaRks3cjhqYUVnek1aY3NBSnFGX0s5cVY2WWg5YllBOGVXYUtvNG0wSmlLdVEyRGxhR0p4b3pqV0N4M2E3Mk9ibGIwY3FrWXVuREd4NF9xRkFGT3BVdFZ3TFFZUnhSTEdEZzNsckpU?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq (GELS) calls Special Meeting on convertible note share issuance and 9.99% cap", "summary": "Gelteq Limited has called a Special Meeting for shareholders to approve the issuance of shares related to a new convertible note financing with an institutional investor. This approval is necessary under Nasdaq Listing Rule 5635(d) for the company to issue shares upon conversion ", "url": "https://www.stocktitan.net/sec-filings/GELS/6-k-gelteq-ltd-current-report-foreign-issuer-945c41bf3557.html", "source_name": "Stock Titan", "published_at": "2026-06-02T20:22:09", "published_display": "02 Jun 2026 20:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/gelteq-commences-veterinary-medicine-clinical-120000231.html", "source_name": "GlobeNewswire", "published_at": "2026-05-20T12:00:00+00:00", "published_display": "20 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/gelteq-announces-usd-3-5-120000614.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T12:00:00+00:00", "published_display": "12 May 2026 12:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "With Gelteq Stock Sliding, Have You Assessed The Risk?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPWGFWVmg2cjJnc3J6Zkk4Y0RPRUczRVZyd0NvZmhzU2NkRnVrSzZ5UFpoZEU3LU40OE0wLXd5cThJdU94Z0RyZFdRajgwZkJtaUZlUHdMbnVIY1dYMWRiNEpfT3FOb0VlZVRkcmRKZXJjejJhYjlpd1ZxY1ZYTlJlVkQ1b2RMWW1GQk5pSVc4S05jNXZObWtpR29oY1Rxdkt2a2VweTQ3RjF1TlNERlNfUDJCcGphRG1UZlU4Nk90RkY?oc=5", "source_name": "Trefis", "published_at": "2025-12-21T08:00:00+00:00", "published_display": "21 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Gelteq(GELS) Stock Options Chain | Quotes & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwJBVV95cUxPX2hyakR1bEQ0aUd0dDJvNzVWRHRCa2hQd2FvMU9UWjBDYnJ1bUZwcnRNc2doNk1QajVPYkJ1blVwX1dZMlBQdUhPaThwT3dHRDRaVTdBQ3E1WWhPbHJ5U19Dckh5cW9ZaW5DNjVEQVRSbDlPQUdlVTlya3JHeWwzMlkzQnBocW1oNXE3eGZ1YUE2R1Zub184VWQ2bDhjUGVnbEJNNzRnUkxFQUVuTmVrUnJjMjliY0lTYWc1ZVhDTmtyTFF2SEw5Y3RMS0Y0MjM2R1hYQVdfLWx1dWNrMmhJVXU0b1JoMXBLUTlzbXlmTDQ5RzkydFp1WkhOSFFmSno2Yy1GMDN6WDkzY0xOUUhlaW12eUYxYnRQaHhXV2h6bklpNDVWeDN3TlRRbw?oc=5", "source_name": "Moomoo", "published_at": "2026-07-14T01:56:25+00:00", "published_display": "14 Jul 2026 01:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq (GELS) wins shareholder approval and closes $2.5M second tranche note", "summary": "Gelteq Limited (GELS) announced that its shareholders approved a debt financing proposal, allowing the company to close the second tranche of a convertible debt facility. This approval led to Gelteq receiving $2.5 million in proceeds from an institutional investor, net of a $375,", "url": "https://www.stocktitan.net/sec-filings/GELS/6-k-gelteq-ltd-current-report-foreign-issuer-a2a80269a743.html", "source_name": "Stock Titan", "published_at": "2026-07-03T03:10:07", "published_display": "03 Jul 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GELS - Gelteq Ltd Short Interest", "summary": "This article provides a detailed overview of Gelteq Ltd's (GELS) short interest and key financial metrics as of July 1, 2026. It includes stock performance, valuation ratios, income statement data, balance sheet figures, and insider/institutional ownership percentages. The data i", "url": "https://finviz.com/stock?t=GELS&ta=1&p=d&ty=si&b=1", "source_name": "Finviz", "published_at": "2026-07-01T14:09:15", "published_display": "01 Jul 2026 14:09", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GELS - Gelteq Ltd Latest SEC Filings", "summary": "This article provides the latest SEC filing information for Gelteq Ltd (GELS), including its last trading close of $0.6600 on July 1st, alongside a comprehensive overview of the company's financial data, performance metrics, and key ratios. It details market capitalization, incom", "url": "https://finviz.com/stock?t=GELS&ty=lf&page=1", "source_name": "Finviz", "published_at": "2026-07-01T07:09:15", "published_display": "01 Jul 2026 07:09", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq (GELS) faces $5.3M working capital deficit and rising debt", "summary": "Gelteq (GELS), an Australian biotech, reported a net loss of AUD$3.74 million for the six months ended December 31, 2025, and a sharp decline in cash to AUD$9,349. The company faces severe liquidity pressure with a working capital deficit of AUD$5.34 million and rising total borr", "url": "https://www.stocktitan.net/sec-filings/GELS/6-k-gelteq-ltd-current-report-foreign-issuer-06b43cfff8a6.html", "source_name": "Stock Titan", "published_at": "2026-06-30T21:39:46", "published_display": "30 Jun 2026 21:39", "sentiment": "negative", "sentiment_pct": 13, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Ltd (GELS) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Gelteq Ltd (GELS), including its current stock performance, market capitalization, and various analytical dimensions like financial health, valuation, price momentum, and risk assessment. It highlights that critical data for EPS, Rev", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-gels/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T09:09:40", "published_display": "18 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Ltd (GELS) Institutional Confidence", "summary": "This article provides details on the institutional confidence score for Gelteq Ltd (GELS), including its current stock price, market cap, and a list of major institutional shareholders. It highlights the shares held by key individuals and firms, as well as recent changes in their", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-gels/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T06:09:40", "published_display": "18 Jun 2026 06:09", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Ltd (GELS) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a brief valuation analysis for Gelteq Ltd (GELS), highlighting key financial metrics such as P/E, P/B, P/S, and P/CF ratios. It notes that relevant data for these metrics have not yet been disclosed by the company. The article also includes current stock per", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-gels/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T03:09:22", "published_display": "18 Jun 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Ltd (GELS) Financial Health: Profitability & Balance Sheet Analysis", "summary": "The article provides an analysis of Gelteq Ltd's (GELS) financial health, focusing on profitability and balance sheet aspects. It notes that relevant financial data for several key metrics, including cash and cash equivalents, total assets, operating profit, and free cash flow, h", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-gels/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T21:09:22", "published_display": "17 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs", "summary": "Gelteq has announced a significant corporate update, detailing the launch of both veterinary and human clinical trials for its patented technology. The company also reported an expansion of its pharmaceutical pipeline across multiple programs, indicating a broader application of ", "url": "https://news.futunn.com/en/post/74731578/gelteq-provides-corporate-update-launching-veterinary-and-human-clinical-trials", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-06-17T20:09:16", "published_display": "17 Jun 2026 20:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Ltd (GELS) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides historical dividend and stock split information for Gelteq Ltd (GELS). It notes that Gelteq Ltd has distributed $0.00 in dividends over the past five years and currently has no recorded stock split data. The company's stock is trading at $1.040 with an 8.77%", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-gels/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T20:09:16", "published_display": "17 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq lines up first human trial, vet study and $3.5M financing", "summary": "Gelteq (NASDAQ: GELS) announced significant clinical, commercial, and financing progress, including a commenced veterinary antiparasitic trial, a first human clinical trial expected next quarter, and a preclinical diabetes study. The company secured up to $3.5 million in strategi", "url": "https://www.stocktitan.net/news/GELS/gelteq-provides-corporate-update-launching-veterinary-and-human-bpx04dh0crj7.html", "source_name": "Stock Titan", "published_at": "2026-06-17T12:40:31", "published_display": "17 Jun 2026 12:40", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GELS - Gelteq Ltd Earnings", "summary": "This article provides comprehensive financial data for Gelteq Ltd (GELS), including its market capitalization, income, sales, and various performance metrics. It details key financial ratios, EPS figures, insider ownership, institutional ownership, and stock performance over diff", "url": "https://finviz.com/stock?t=GELS&ta=1&p=d&ty=ea&b=1", "source_name": "Finviz", "published_at": "2026-06-17T03:39:43", "published_display": "17 Jun 2026 03:39", "sentiment": "negative", "sentiment_pct": 13, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$Gelteq (GELS.US)$ thank you", "summary": "This article is a brief post from a user named \"Rakeem tha Dream\" on the Moomoo Community platform, expressing gratitude for $Gelteq (GELS.US)$. The content highlights the social interaction aspect of the platform where users can share thoughts and engage in discussions about sto", "url": "https://www.moomoo.com/community/feed/gelteq-gels-us-thank-you-116753455251461", "source_name": "Moomoo", "published_at": "2026-06-16T08:10:23", "published_display": "16 Jun 2026 08:10", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GELS Stock Rockets On Momentum As Traders Pile In", "summary": "Gelteq Limited (GELS) stock has surged by 47.47% due to strong investor optimism regarding its commercialization progress, making it a focus for momentum traders. Despite its small revenue, high price-to-sales ratio, and negative profitability, the stock has shown explosive chart", "url": "https://www.timothysykes.com/news/gelteq-limited-gels-news-2026_06_15/", "source_name": "Timothy Sykes", "published_at": "2026-06-15T13:41:39", "published_display": "15 Jun 2026 13:41", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GELS Stock Rockets On Massive Volume As Traders Pile In", "summary": "Gelteq Limited (GELS) stock surged 48.99% on massive volume, driven by speculative trading and momentum rather than strong fundamentals. The company, with minimal revenue and negative returns, is being treated by traders as a high-volatility, high-reward opportunity, with its sto", "url": "https://stockstotrade.com/news/gelteq-limited-gels-news-2026_06_15/", "source_name": "StocksToTrade", "published_at": "2026-06-15T13:41:39", "published_display": "15 Jun 2026 13:41", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$Gelteq (GELS.US)$ early catch\u2026LG\u2026\ud83c\udfce\ud83d\udc4d\ud83c\udfff\ud83d\udd25\ud83d\udd25\ud83d\udd25\ud83d\udd25\ud83d\udd25\ud83c\udfc1", "summary": "The article is a brief post from a user named Team Crawford on the moomoo platform, expressing enthusiasm for Gelteq (GELS.US). The post includes emojis suggesting excitement and a \"good game\" or \"let's go\" sentiment. It appears to be a social media-style update rather than an an", "url": "https://www.moomoo.com/community/feed/gelteq-gels-us-early-catch-lg-116732418654213", "source_name": "Moomoo", "published_at": "2026-06-15T08:40:43", "published_display": "15 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq\u00ae Technology for Animal Health Applications", "summary": "Gelteq announced the successful completion of veterinary palatability trials with Kemin Industries, validating their Gelteq\u00ae technology for animal health applications. The trials showed strong canine acceptance of products, even those with bitter compounds, confirming the technol", "url": "https://www.manilatimes.net/2026/06/13/tmt-newswire/globenewswire/gelteq-successfully-completes-veterinary-palatability-trials-with-kemin-further-validating-gelteq-technology-for-animal-health-applications/2364638", "source_name": "The Manila Times", "published_at": "2026-06-12T18:10:16", "published_display": "12 Jun 2026 18:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq's Tasty Tech May End the Pet-Pilling War and Reshape Animal Health", "summary": "Gelteq, an Australian biotech firm, has successfully completed palatability trials for its gel-based drug delivery platform, Gelteq\u00ae, in collaboration with Kemin Industries. This technology aims to solve the widespread problem of pet medication non-compliance by effectively maski", "url": "https://briefglance.com/articles/gelteqs-tasty-tech-may-end-the-pet-pilling-war-and-reshape-animal-health", "source_name": "BriefGlance", "published_at": "2026-06-12T17:41:39", "published_display": "12 Jun 2026 17:41", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dogs accept gels that hide bitter medicine, Gelteq trials show", "summary": "Gelteq (ASX:GELS) has successfully completed veterinary palatability trials with Kemin Industries, validating its gel-based delivery platform for animal health. The trials demonstrated strong canine acceptance and effective masking of bitter flavors, confirming the technology's p", "url": "https://www.stocktitan.net/news/GELS/gelteq-successfully-completes-veterinary-palatability-trials-with-dllbm93mgtvp.html", "source_name": "Stock Titan", "published_at": "2026-06-12T16:29:31", "published_display": "12 Jun 2026 16:29", "sentiment": "positive", "sentiment_pct": 90, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Going On With Gelteq Stock Friday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPc1VBZTFOUWtPZWZ4Z1hIdjlITTZBd21fRFcybUZPdVhLT2dRUFZhQUE1N2QyRVpYRWtKZ3JwR3hzVGQ5NXhHV1JSQVZvZWRpQjh0bnhpUmZiNG82RDgzQWViakZOTWR6aWNWVkhuU1RBU0R1NGh4bG5CR3E1elVrZFh6MXBBa1YtaTI3MDB0SVF4MHVWbGc?oc=5", "source_name": "Sahm", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Jumps After GELS Hits Several Nasdaq Volatility Pauses", "summary": "Shares of Gelteq Limited (NASDAQ: GELS) surged by about 56% to $0.805 on June 11, 2026, experiencing multiple Nasdaq volatility pauses as its stock price fluctuated significantly between $0.5145 and $2.01 with exceptionally high trading volume. The surge comes as the Melbourne-ba", "url": "https://ts2.tech/en/gelteq-jumps-after-gels-hits-several-nasdaq-volatility-pauses/", "source_name": "TechStock\u00b2", "published_at": "2026-06-11T18:39:08", "published_display": "11 Jun 2026 18:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq (Nasdaq:GELS) - Stock Analysis", "summary": "This Simply Wall St analysis of Gelteq (Nasdaq:GELS) highlights its current stock performance, fundamental statistics, and recent company announcements. The report details the company's valuation, growth prospects, financial health, and risks, including its highly volatile share ", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gels/gelteq", "source_name": "Simply Wall Street", "published_at": "2026-06-11T17:09:27", "published_display": "11 Jun 2026 17:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$Gelteq (GELS.US)$ \ud83d\udc4d sold all already. thank you![Drool][Cool Guy][Rich][Peace][Blessing]", "summary": "A Moomoo user, ABC88, announced that they have sold all their shares in Gelteq (GELS.US), expressing gratitude. The post, made in the Moomoo Community, includes various emojis suggesting satisfaction and profit.", "url": "https://www.moomoo.com/community/feed/gelteq-gels-us-sold-all-already-thank-you-116733309288454", "source_name": "Moomoo", "published_at": "2026-06-11T07:39:07", "published_display": "11 Jun 2026 07:39", "sentiment": "positive", "sentiment_pct": 68, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq establishes Centre of Excellence in China to accelerate product development", "summary": "Australia-based Gelteq has announced the establishment of a new Centre of Excellence in Guangdong Province, China. This strategic regional hub will strengthen Gelteq's globally integrated development platform by leveraging local infrastructure, technical expertise, and innovation", "url": "https://www.biospectrumasia.com/news/26/27748/gelteq-establishes-centre-of-excellence-in-china-to-accelerate-product-development-.html", "source_name": "BioSpectrum Asia", "published_at": "2026-06-05T15:40:18", "published_display": "05 Jun 2026 15:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion", "summary": "Gelteq (GELS) has announced the establishment of a new Center of Excellence in Guangdong Province, China, aiming to accelerate product development and commercial expansion. This strategic hub will provide access to China's growing biotech and pharma ecosystem, enhancing formulati", "url": "https://www.stocktitan.net/news/GELS/gelteq-establishes-center-of-excellence-in-china-to-accelerate-vhfqa5qhaawp.html", "source_name": "Stock Titan", "published_at": "2026-06-04T12:39:08", "published_display": "04 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq sets up Guangdong hub as China biotech deals near $60B", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOcF9ONmRSSEdLUHhmOUdPdi1GTTBlNjI0SmJlaV9JZGdzRUlTbnBiMkN5NFZtVlVkLUE0aUsxWWtLUy1yc1VObmlfdDFEbFpBc0xaRks3cjhqYUVnek1aY3NBSnFGX0s5cVY2WWg5YllBOGVXYUtvNG0wSmlLdVEyRGxhR0p4b3pqV0N4M2E3Mk9ibGIwY3FrWXVuREd4NF9xRkFGT3BVdFZ3TFFZUnhSTEdEZzNsckpU?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq (GELS) calls Special Meeting on convertible note share issuance and 9.99% cap", "summary": "Gelteq Limited has called a Special Meeting for shareholders to approve the issuance of shares related to a new convertible note financing with an institutional investor. This approval is necessary under Nasdaq Listing Rule 5635(d) for the company to issue shares upon conversion ", "url": "https://www.stocktitan.net/sec-filings/GELS/6-k-gelteq-ltd-current-report-foreign-issuer-945c41bf3557.html", "source_name": "Stock Titan", "published_at": "2026-06-02T20:22:09", "published_display": "02 Jun 2026 20:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/gelteq-commences-veterinary-medicine-clinical-120000231.html", "source_name": "GlobeNewswire", "published_at": "2026-05-20T12:00:00+00:00", "published_display": "20 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/gelteq-announces-usd-3-5-120000614.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T12:00:00+00:00", "published_display": "12 May 2026 12:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "With Gelteq Stock Sliding, Have You Assessed The Risk?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPWGFWVmg2cjJnc3J6Zkk4Y0RPRUczRVZyd0NvZmhzU2NkRnVrSzZ5UFpoZEU3LU40OE0wLXd5cThJdU94Z0RyZFdRajgwZkJtaUZlUHdMbnVIY1dYMWRiNEpfT3FOb0VlZVRkcmRKZXJjejJhYjlpd1ZxY1ZYTlJlVkQ1b2RMWW1GQk5pSVc4S05jNXZObWtpR29oY1Rxdkt2a2VweTQ3RjF1TlNERlNfUDJCcGphRG1UZlU4Nk90RkY?oc=5", "source_name": "Trefis", "published_at": "2025-12-21T08:00:00+00:00", "published_display": "21 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 68, "total_relevant": 31, "sentiment_summary": {"positive": 14, "negative": 6, "neutral": 11, "score": 56, "total": 31, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 9.9, "count": 18}, {"event": "earnings", "label": "Earnings", "weight": 4.4, "count": 8}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.65, "count": 3}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 14, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 0.53, "latest_week": "2026-07-10", "one_week_move": -9.4, "four_week_move": -47.0, "twelve_week_move": -25.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.425683, "market_dynamics_buy_signal": false, "relative_strength": -55.297878, "fair_value_gap": -61.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 39.527, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-9.4% over one week, -47.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 65, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 7}, {"label": "TradingKey", "count": 5}, {"label": "Moomoo", "count": 4}, {"label": "Finviz", "count": 3}, {"label": "GlobeNewswire", "count": 2}, {"label": "\u5bcc\u9014\u725b\u725b", "count": 1}, {"label": "Timothy Sykes", "count": 1}, {"label": "StocksToTrade", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 31}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 18}, {"label": "Earnings", "count": 8}, {"label": "Regulatory and legal", "count": 3}, {"label": "Balance sheet", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "31", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-9.4% over one week, -47.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Gelteq(GELS) Stock Options Chain | Quotes & News"}], "updated_at": "2026-07-16T08:13:40.169417+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}